NVAX
Novavax, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website novavax.com
- Employees(FY) 1992
- ISIN US6700024010
Performance
-4.73%
1W
-20.83%
1M
-42.01%
3M
-38.05%
6M
+67.92%
YTD
+41.4%
1Y
Profile
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Technical Analysis of NVAX 2024-11-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-18 09:01
- 2024-11-18 09:00
- 2024-11-15 16:19
Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHS(Investor's Business Daily)
- 2024-11-15 13:19
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell?(Investor's Business Daily)
- 2024-11-15 12:50
- 2024-11-15 12:04
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS(Investor's Business Daily)
- 2024-11-15 10:46
Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick(Yahoo Finance Video)
- 2024-11-15 07:47
- 2024-11-15 07:41
Novavax Covid Variant Vaccine Approved for use in UK(MT Newswires)
- 2024-11-15 06:12
- 2024-11-15 05:51
- 2024-11-15 05:21
- 2024-11-15 02:08
- 2024-11-14 23:04
- 2024-11-14 18:47
- 2024-11-14 16:28
- 2024-11-14 16:28
- 2024-11-14 14:16
- 2024-11-14 05:49
Novavax Third Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
- 2024-11-13 08:13
- 2024-11-13 08:00
- 2024-11-13 02:08
- 2024-11-12 19:00
- 2024-11-12 14:43
- 2024-11-12 12:52
FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine(Pharmaceutical Technology)
- 2024-11-12 10:33
- 2024-11-12 09:48
- 2024-11-12 09:44
- 2024-11-12 09:20
- 2024-11-12 08:45
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.